Derrell Porter

Dr. Derrell D.
Porter is an Independent Director at Acumen Pharmaceuticals, Inc., an Independent Director at Passage Bio, Inc. and a Chief Executive Officer & Director at CTRL Therapeutics, Inc. He is on the Board of Directors at Acumen Pharmaceuticals, Inc., Passage Bio, Inc., CTRL Therapeutics, Inc. and Biosortia Pharmaceuticals, Inc. Dr. Porter was previously employed as a Chief Executive Officer by Cellevolve Bio, Inc., a Senior Vice President & Global Head-Commercial by Atara Biotherapeutics, Inc., a Vice President by Gilead Sciences, Inc., a Sales Manager & Director-Corporate Development by AbbVie, Inc., and a Director-Corporate Development & Sales Manager by Amgen, Inc. He also served on the board at Alliance for Regenerative Medicine and Portal Innovations LLC.
He received his undergraduate degree from the University of California, Los Angeles, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from Perelman School of Medicine.